About Acino
Acino is a Healthcare company based in Zurich (Switzerland) founded in 1836, and was acquired by ADQ in September 2021. Generic drugs are manufactured by Acino in Switzerland. It operates on a Direct-to-Consumer (D2C), Reseller / Distribution, and Licensing Model model. Acino has completed 1 acquisition, including M8 Pharmaceuticals. Its chief executive, as recorded, is Steffen Saltofte. Acino offers products and services including Innovative Medicines, Generic Medicines, and Manufacturing Services. Its focus areas include Pharmaceuticals and Drug Manufacturing. Its legal entity is Acino International AG.
Company details
Acino is involved in the development, manufacturing, and marketing of innovative and generic medicines across various therapeutic areas. Operations are conducted in regions including Africa, Latin America, the Middle East, Türkiye, North Africa, Ukraine, and Eurasian countries. Advanced drug delivery systems are produced, focusing on dispersible and complex modified release formulations. Partnerships are established with global pharma companies for in-licensing and out-licensing of products. A commitment to sustainability and health matters is maintained through educational initiatives on conditions like hypertension and infectious diseases.
- Headquarters Zurich, Switzerland
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website acino.swiss
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by ADQ (Sep 2021)
- Legal Name Acino International Ag
- InvestorsADQ
& 2 more
- Investments & Acquisitions
- Acquired by
Products & Services of Acino
Acino offers a comprehensive portfolio of products and services, including Innovative Medicines, Generic Medicines, and Manufacturing Services.
Innovative medicines are developed for various health conditions.
Generic medicines are distributed to improve healthcare access.
Manufacturing services are provided for pharmaceutical product development.
Apps and channels of Acino
its YouTube channel Acino has 591 subscribers and 29 videos.
Videos from Acino
The most watched videos on Acino's YouTube channel, Acino (591 subscribers). Click a video to play it here.
More on Acino.
Investors in Acino
Acino has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include ADQ, Nordic Capital and Avista Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
ADQ is recognized as a leading sovereign investor focused on sustainable economic transformation in Abu Dhabi. | adq.ae | Abu Dhabi, United Arab Emirates | ||
| nordiccapital.com | ||||
Private equity investments are focused on the United States market. | avistacap.com | New York, United States |
Investor details for Acino
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Acino
88 people are tracked at Acino (36 in leadership, 52 in team).
| Name | Role | Group |
|---|---|---|
Steffen Saltofte | CEO | Leadership |
Saulo Xavier | Head Of Legal, Compliance And Data Privacy Officer Latam | Leadership |
Ai See | Senior Qa/qa Compliance Head | Leadership |
Dirk Kartenbender | Global Head Of Strategy And Operational Excellence | Leadership |
Christina Peusch | Chief Legal & Integrity And Compliance Officer | Leadership |
Nadia Benabdellah | HR Director Middle East & Africa | Leadership |
Sherusha Naidoo | Human Resources Director | Leadership |
Richard Letzelter | Chief Human Resources Officer | Leadership |
Adil El Bouty | Regional Supply Chain Director Middle East, Turkey And Africa | Leadership |
Jonny Norder | Head Facility Management And Infrastructure | Leadership |
Fatma Elbaradie | HR Director - META | Leadership |
Andrey Dorofeev | Strategy Director | Leadership |
Mohamed al-Bashir Aref | Head Of Supply Chain, GCC | Leadership |
Schenella Menda | Head Of Licensing, META | Leadership |
Isabelle Bonelli | Corporate Legal Director | Leadership |
Annika Feracioli | Head Of Tax & Treasury | Leadership |
Laura Gobet-Gutmann | Head Of Group Reporting | Leadership |
Nadine Mutter | People And Culture Business Partner | Leadership |
Carina Moll | Global Human Resources Business Partner | Leadership |
Trevor Reddy | Head Of Market Access, Tenders & Pricing | Leadership |
68 more people are available in the full profile.
Complete people profiles for Acino
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acino
Acino has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include M8 Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharmaceutical company develop and commercialize leading original medicines | m8pharmaceuticals.com | Berwyn, United States | 2007 | Dec 2023 | •••• |
Complete acquisition details for Acino
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Acino
4 dated milestones of Acino across 187 years, from founding to its latest funding, stage changes and deals.
- Founded Acino is founded.
- Exit Acquired by Nordic Capital.
- Exit Acquired by ADQ.
- Acquisition Acquires M8 Pharmaceuticals.
Web traffic of Acino
The website of Acino (acino.swiss) receives about 8.5K visits a month and ranks #2,030,551 among all websites worldwide, #2,763 in Biotechnology and Pharmaceuticals.
- Monthly visits8.5K
▼ 23.4% vs previous month
- Unique visitors4.5K
per month
- Global rank#2,030,551
among all websites
- Category rank#2,763
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.9
- Average visit27 sec
- DevicesDesktop 43% · Mobile 57%
Websites whose visitors overlap most with Acino. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| contractpharma.com | 100% | 67.7K | #631,663 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acino
Acino was founded in 1836.
Acino is headquartered in Zurich, Switzerland.
Steffen Saltofte is the CEO of Acino, as recorded in our data.
Acino is involved in the development, manufacturing, and marketing of innovative and generic medicines across various therapeutic areas. Operations are conducted in regions including Africa, Latin America, the Middle East, Türkiye, North Africa, Ukraine, and Eurasian countries. Advanced drug delivery systems are produced, focusing on dispersible and complex modified release formulations. Partnerships are established with global pharma companies for in-licensing and out-licensing of products. A commitment to sustainability and health matters is maintained through educational initiatives on conditions like hypertension and infectious diseases.
Acino offers Innovative Medicines, Generic Medicines, and Manufacturing Services.
Acino has made 1 acquisition, including M8 Pharmaceuticals.
Acino has 3 investors. Key investors include ADQ, Nordic Capital, and Avista Capital Partners.
Acino operates through Acino International Ag.
Yes. Acino was acquired by ADQ in September 2021.